Inverse Correlation between Expression of Inducible Nitric Oxide Synthase Activity and Production of Metastasis in K-1735 Murine Melanoma Cells

Cancer Research

Volumn 54, Issue 3, 1994, Pages 789-793

  Dong, Zhongyun ^a   Staroselsky, Alexander H ^a   Qi, Xiaoxia ^a   Xie, Keping ^a   Fidler, Isaiah J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CULTURE MEDIUM; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME INDUCTION; HYBRID CELL; ISOTOPE LABELING; LUNG METASTASIS; MELANOMA; MELANOMA CELL; MOLECULAR CLONING; MOUSE; NONHUMAN; ORGAN DISTRIBUTION; PRIORITY JOURNAL;

AMINO ACID OXIDOREDUCTASES; ANIMAL; CALCIUM; ENZYME INDUCTION; IDOXURIDINE; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN-1; IODINE RADIOISOTOPES; LIPOPOLYSACCHARIDES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C3H; NITRIC OXIDE; NITRIC-OXIDE SYNTHASE; SUPPORT, U.S. GOV'T, P.H.S.; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR;

EID: 0027958098     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Fidler, I. J. Critical factors in the biology of human cancer metastasis. Cancer Res., 50: 6130-6138, 1990.
2. Nicolson, G. Cancer metastasis: tumor cells and host-organ properties important in metastasis to specific secondary sites. Biochim. Biophys. Acta, 948: 175-22A, 1986.
3. Radinsky, R. Growth factors and their receptors in metastasis. Semin. Cancer Biol., 2: 169-177, 1991.
4. Fidler, I. J. Macrophages and metastasis-a biological approach to cancer therapy. Cancer Res., 45: 411A-4726, 1985.
5. Price, J. E., Aukerman, S. L., and Fidler, I. J. Evidence that the process of murine melanoma metastasis is sequential and selective and contains stochastic elements. Cancer Res., 46: 5172-5178, 1986.
6. Fidler, I. J. Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125I-5-iodo-2′-deoxyuridine. J. Natl. Cancer Inst., 46: 773-783, 1970.
7. Weiss, L. Metastatic inefficiency: causes and consequences. Cancer Metastasis Rev., 3: 1-24, 1986.
8. Weiss, L., Orr, F. W., and Honn, K. V. Interactions between cancer cells and the microvasculature: a rate regulator for metastasis. Clin. Exp. Metastasis, 7: 127-167, 1989.
9. Glaves, D. Intravascular death of disseminated cancer cells mediated by superoxide anion. Invasion Metastasis, 6: 101-111, 1986.
10. Weiss, L., and Dimitrov, R S. Mechanical aspects of the lungs as cancer cell killing organs during hematogenous metastasis. J. Theor. Biol., 121: 307-321, 1986.
11. Sato, H., and Suzuki, M. Deformability and viability of tumor cells by transcapillary passage with reference to organ affinity in metastasis in cancer. In: L. Weiss (ed.), Fundamental Aspects of Metastasis, pp 311-317. Amsterdam: North-Holland, 1976.
12. Hofraann, M., Rudy, W., Zoller, M., Tolg, C., Ponta, H., Jerrlich, P., and Gunthert, U. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res., 57: 5292-5297, 1991.
13. Frixen, U. H., Behrens, J., Sachs, M., Eberle, G., Mass, B., Warda, A., Lochner, D., and Birchmeier, W. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol., 113: 173-185, 1991.
14. Weiss, L. Biomechanical interactions of cancer cells with the microvasculature during hematogenous metastasis. Cancer Metastasis Rev., 11: 227-235, 1992.
15. Sugimoto, Y., Oh-hara, T., Watanabe, M., Uamori, T., and Isuruo, T. Acquisition of metastatic ability in hybridomas between two low metastatic clones of murine colon adenocarcinoma 26 defective in either platelet-aggregating activity or in vivo growth potential. Cancer Res., 47: 3115-3117, 1987.
16. Isuruo, T., Kawabata, H., Iida, H., and Yomori, T. Tumor-induced platelet aggregation and growth-promoting factors as determinants for successful tumor metastasis. Clin. Exp. Metastasis, 7: 25-33, 1986.
17. Wiltrout, R. H., Frost, P., Morrison, M. K., and Kerbel, R. S. Immune-mediated arrest and reversal of established visceral metastasis in athymic mice. Cancer Res., 39: 4034-4041, 1979.
18. Hanna, N., and Fidler, I. J. The role of natural killer cells in the destruction of circulating tumor emboli. J. Natl. Cancer Inst., 65: 801-809, 1980.
19. Herberman, R. B. Natural killer cells. Prog. Clin. Biol. Res., 288: 161-167, 1989.
20. Whitworth, P. W., Pak, C. C., Esgro, J., Kleinerman, E. S., and Fidler, I. J. Macrophages and cancer. Cancer Metastasis Rev., 8: 319-351, 1990.
21. Poste, G., and Fidler, I. J. The pathogenesis of cancer metastasis. Nature (Lond.), 283: 139-146, 1980.
22. Li, L., Nicolson, G. L., and Fidler, I. J. Direct in vitro lysis of metastatic tumor cells by cytokine-activated murine vascular endothelial cells. Cancer Res., 51: 245-254, 1991.
23. Li, L., Kilbourn, R. G., Adams, J., and Fidler, I. J. Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells. Cancer Res., 51: 2531-2535, 1991.
24. Stuehr, D. J., and Nathan, C. F. Nitric oxide, a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med., 169: 1543-1555, 1989.
25. Stuehr, D. J., and Griffith, O. W Mammalian nitric oxide synthase. In: A. Meister (ed.), Advances in Enzymology and Related Areas of Molecular Biology, Vol. 65, pp. 287-346. New York: Interscience, 1992.
26. Hibbs, J. B., Jr., Taintor, R. R., and Vavrin, Z. Macrophage cytotoxicity: role for L-arginine deiminase activity and amino nitrogen to nitrate. Science (Washington DC), 235: 473-476, 1987.
27. Palmer, R. M. J., Rees, D. D., Ashton, D. S., and Moncada, S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature (Lond.), 333: 664-666, 1988.
28. Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E., and Chaudhuri, G. Endothe-lium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA, 87: 5193-5197, 1990.
29. Radomski, M. W., Palmer, R. M. J., and Moncada, S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. USA, 87: 5193-5197, 1990.
30. Radomski, M. W., Palmer, R. M. J., and Moncada, S. Characterization of the L-arginine: nitric oxide pathway in human platelets. Br. J. Pharmacol., 101: 325-328, 1990.
31. Busse, R., and Mulsch, A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett., 275: 87-90, 1990.
32. Xie, Q., Cho, H. J., Calaycay, J., Mumford, R. A., Swiderek, K. M., Lee, T. D., Ding, A., Troso, T., and Nathan, C. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science (Washington DC), 256: 225-228, 1992.
33. Geller, D. A., Lowenstein, C. J., Shapiro, R. A., Nussler, A. K., Silvio, M. D., Wang, S. C., Nakayama, D. K., Simmons, R. L., Snyder, S. H., and Billiar, T. R. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc. Natl. Acad. Sci. USA, 90: 3491-3495, 1993.
34. Fidler, I. J., and Schroit, A. J. Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self. Biochim. Biophys. Acta, 948: 151-173, 1988.
35. Amber, I. J., Hibbs, J. B., Jr., Taintor, R. R., and Vavrin, Z. Cytokines induce an L-arginine-dependent effector system in nonmacrophage cells. J. Leukocyte Biol., 44: 58-65, 1988.
36. Arroyo, C. M., Forray, C., El-Fakahany, E. E., and Rosen, G. M. Receptor-mediated generation of an EDRF-like intermediate in a neuronal cell line detected by spin trapping techniques. Biochem. Biophys. Res. Commun., 170: 1177-1183, 1990.
37. Forstermann, U., Gorsky, L. D., Pollock, J., Ishii, K., Schmidt, H. H. H. W., Heller, M., and Murad, F. Hormone-induced biosynthesis of endothelium-derived relaxing factor/nitric oxide-like material in N1E-115 neuroblastoma cells requires calcium and calmodulin. Mol. Pharmacol., 38: 7-13, 1990.
38. Fast, D. J., Lynch, R. C., and Leu, R. W. Nitric oxide production by tumor targets in response to TNF: paradoxical correlation with susceptibility to TNF-mediated cytotoxicity without direct involvement in the cytotoxic mechanism. J. Leukocyte Biol., 52: 255-261, 1992.
39. Radomski, M. K., Jenkins, D. C., Holmes, L., and Moncada, S. Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Res., 51: 6073-6078, 1991.
40. Xie, K., and Fidler, I. J. Induction of apoptosis in transformed fibroblasts can be mediated via endogenous and exogenous nitric oxide. Proc. Am. Assoc. Cancer Res., 34: 95, 1993.
41. Kripke, M. L. Speculations on the role of ultraviolet radiation in the development of malignant melanoma. J. Natl. Cancer Inst, 63: 541-548, 1979.
42. Talmadge, J. E., and Fidler, I. J. Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors. J. Natl. Cancer Inst., 69: 975-980, 1982.
43. Aukerman, S. L., Price, J. E., and Fidler, I. J. Different deficiencies in the prevention of tumorigenic-low metastatic murine K-1735b melanoma cells from producing metastases. J. Natl. Cancer Inst., 77: 915-924, 1986.
44. Talmadge, J. E., Wolman, S. R., and Fidler, I. J. Evidence for the clonal origin of spontaneous metastases. Science (Washington DC), 217: 361-363, 1982.
45. Staroselsky, A. H., Pathak, S., Chernajovsky, Y., Tucker, S. I., and Fidler, I. J. Predominance of the metastatic phenotype in somatic cell hybrids of the K-1735 murine melanoma. Cancer Res., 57: 6292-6298, 1991.
46. Fidler, I. J., and Talmadge, J. E. Evidence that intravenously derived murine pulmonary melanoma metastases can originate from the expansion of a single tumor cell. Cancer Res., 46: 5167-5171, 1986.
47. Ding, A., Nathan, C., and Stuehr, D. J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol., 141: 2407-2412, 1988.
48. Stuehr, D. J., Kwon, N. S., Gross, S. S., Thiel, B. A., Levi, R., and Nathan, C. F. Synthesis of nitrogen oxides from L-arginine by macrophage cytosol: requirement for inducible and constitutive components. Biochem. Biophys. Res. Commun., 161: 420-426, 1989.
49. Schmidt, H. H. H. W., Warner, T. D., Nakane, M., Forstermann, U., and Murad, F. Regulation and subcellular location nitrogen oxide synthases in RAW264.7 macrophages. Mol. Pharmacol., 41: 615-624, 1992.
50. Stuehr, D. J., Kwon, N. S., and Nathan, C. J. FAD and GSH participate in macrophage synthesis of nitric oxide. Biochem. Biophys. Res. Commun., 168: 558-565, 1990.
51. Dong, Z., Qi, Z., Xie, K., and Fidler, I. J. Protein tyrosine kinase inhibitors decrease induction of nitric oxide synthase activity in LPS-responsive and LPS-nonresponsive murine macrophages. J. Immunol., 151: 2717-2724, 1993.
52. Sarin, M., Souvannavong, V., and Adam, A. Nitric oxide synthase induces macrophage death by apoptosis. Biochem. Biophys. Res. Commun., 191: 503-508, 1993.